These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | ||||
|
|
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | ||||
|
|
|
||||||||||
|
(State or other jurisdiction of
incorporation or organization) |
(I.R.S. Employer
Identification No.) |
||||||||||
|
|
|
|
|||||||||
|
|
|
||||||||||
| (Address of principal executive offices) | (Zip Code) | ||||||||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
|
|
|
|
||||||
| Large accelerated filer |
¨
|
|
ý
|
|||||||||||
| Non-accelerated filer | ¨ | Smaller reporting company |
|
|||||||||||
| Emerging growth company |
|
|||||||||||||
| Table of Contents |
Page
Number |
|||||||
| PART I. | FINANCIAL INFORMATION | |||||||
| ITEM 1. | Consolidated Financial Statements (Unaudited) | |||||||
| ITEM 2. | ||||||||
| ITEM 3. | ||||||||
| ITEM 4. | ||||||||
| PART II. | OTHER INFORMATION | |||||||
| ITEM 1. | ||||||||
| ITEM 1A. | ||||||||
| ITEM 6. | ||||||||
| ITEM 1. | Consolidated Financial Statements | ||||
| (In millions, except share data) | March 31, 2022 | December 31, 2021 | ||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ |
|
$ |
|
||||
| Receivables, net of allowance for current expected credit losses |
|
|
||||||
| Inventories |
|
|
||||||
| Other current assets |
|
|
||||||
| Total current assets |
|
|
||||||
| Property, plant and equipment |
|
|
||||||
| Accumulated depreciation |
(
|
(
|
||||||
| Property, plant and equipment, net |
|
|
||||||
| Other assets, net |
|
|
||||||
| Total assets | $ |
|
$ |
|
||||
| Liabilities and stockholders' equity | ||||||||
| Current liabilities: | ||||||||
| Current portion of long-term debt | $ |
|
$ |
|
||||
| Accounts payable and accrued liabilities |
|
|
||||||
| Total current liabilities |
|
|
||||||
| Long-term debt |
|
|
||||||
| Liability for pension and other postretirement employee benefits |
|
|
||||||
| Deferred tax liabilities and other long-term obligations |
|
|
||||||
| Total liabilities |
|
|
||||||
| Stockholders’ equity: | ||||||||
|
Preferred stock, par value $
|
|
|
||||||
|
Common stock, par value $
|
|
|
||||||
| Additional paid-in capital |
|
|
||||||
| Retained earnings |
|
|
||||||
| Accumulated other comprehensive loss, net of tax |
(
|
(
|
||||||
| Total stockholders' equity |
|
|
||||||
| Total liabilities and stockholders' equity | $ |
|
$ |
|
||||
| Quarter Ended March 31, | ||||||||
| (In millions, except per-share data) | 2022 | 2021 | ||||||
| Net sales | $ |
|
$ |
|
||||
| Costs and expenses: | ||||||||
| Cost of sales |
|
|
||||||
| Selling, general and administrative expenses |
|
|
||||||
| Other operating charges, net |
|
|
||||||
| Total operating costs and expenses |
|
|
||||||
| Income from operations |
|
|
||||||
| Interest expense, net |
(
|
(
|
||||||
| Debt retirement costs |
(
|
|
||||||
| Other non-operating expense |
(
|
(
|
||||||
| Total non-operating expense |
(
|
(
|
||||||
| Income before income taxes |
|
|
||||||
| Income tax provision |
|
|
||||||
| Net income | $ |
|
$ |
|
||||
| Net income per common share: | ||||||||
| Basic | $ |
|
$ |
|
||||
| Diluted |
|
|
||||||
|
Average shares of common stock used to compute net income per share:
(in thousands) |
||||||||
| Basic |
|
|
||||||
| Diluted |
|
|
||||||
| Quarter Ended March 31, | ||||||||
| (In millions) | 2022 | 2021 | ||||||
| Net income | $ |
|
$ |
|
||||
| Other comprehensive income: | ||||||||
| Defined benefit pension and other postretirement employee benefits: | ||||||||
|
Amortization of actuarial loss included in net periodic cost, net of tax of $
|
|
|
||||||
| Other comprehensive income, net of tax |
|
|
||||||
| Comprehensive income | $ |
|
$ |
|
||||
| Quarter Ended March 31, | ||||||||
| (In millions) | 2022 | 2021 | ||||||
| Operating activities | ||||||||
| Net income | $ |
|
$ |
|
||||
| Adjustments to reconcile net income to net cash flows provided by operating activities: | ||||||||
| Depreciation and amortization |
|
|
||||||
| Equity-based compensation expense |
|
|
||||||
| Deferred taxes |
(
|
(
|
||||||
| Defined benefit pension and other postretirement employee benefits |
|
|
||||||
| Changes in operating assets and liabilities: | ||||||||
| (Increase) decrease in accounts receivable |
(
|
|
||||||
| Increase in inventory |
(
|
(
|
||||||
| Increase in other current assets |
|
(
|
||||||
| Increase (decrease) in accounts payable and accrued liabilities |
|
(
|
||||||
| Other, net |
|
|
||||||
| Net cash flows provided by operating activities |
|
|
||||||
| Investing activities | ||||||||
| Additions to property, plant and equipment, net |
(
|
(
|
||||||
| Net cash flows used in investing activities |
(
|
(
|
||||||
| Financing activities | ||||||||
| Repayments of long-term debt |
(
|
(
|
||||||
| Taxes paid related to net share settlement of equity awards |
(
|
(
|
||||||
| Proceeds from sale of stock under employee awards |
|
|
||||||
| Net cash flows used in financing activities |
(
|
(
|
||||||
| Increase in cash, cash equivalents and restricted cash |
|
|
||||||
| Cash, cash equivalents and restricted cash at beginning of period |
|
|
||||||
| Cash, cash equivalents and restricted cash at end of period | $ |
|
$ |
|
||||
| Supplemental disclosures of cash flow information | ||||||||
| Cash paid for interest, net of amounts capitalized | $ |
|
$ |
|
||||
| Cash paid (received) for income taxes | $ |
|
$ |
(
|
||||
| Cash, cash equivalents, and restricted cash | ||||||||
| Cash and cash equivalents | $ |
|
$ |
|
||||
| Restricted cash included in other assets, net |
|
|
||||||
| Total cash, cash equivalents and restricted cash | $ |
|
$ |
|
||||
| Common Stock | Additional Paid-In Capital |
Retained
Earnings |
Accumulated
Other Comprehensive Loss |
Total
Stockholders' Equity |
||||||||||||||||
| (In millions, except share amounts which are in thousands) | Shares | Amount | ||||||||||||||||||
| Balance at December 31, 2020 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||
| Net income | — | — | — |
|
— |
|
||||||||||||||
|
Stock-based compensation expense
|
— | — |
|
— | — |
|
||||||||||||||
| Issuance of shares under stock plans, net |
|
— |
(
|
— | — |
(
|
||||||||||||||
|
Pension and other postretirement employee benefits, net of tax of $
|
— | — | — | — |
|
|
||||||||||||||
| Balance at March 31, 2021 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||
| Common Stock | Additional Paid-In Capital |
Retained
Earnings |
Accumulated
Other Comprehensive Loss |
Total
Stockholders' Equity |
||||||||||||||||
| (In millions, except share amounts which are in thousands) | Shares | Amount | ||||||||||||||||||
|
Balance at December 31, 2021
|
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||
| Net income | — | — | — |
|
— |
|
||||||||||||||
|
Stock-based compensation expense
|
— | — |
|
— | — |
|
||||||||||||||
| Issuance of shares under stock plans, net |
|
— |
(
|
— | — |
(
|
||||||||||||||
|
Pension and other postretirement employee benefits, net of tax of $
|
— | — | — | — |
|
|
||||||||||||||
| Balance at March 31, 2022 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||
| March 31, 2022 | December 31, 2021 | |||||||
| Term loan maturing 2026, variable interest rate | $ |
|
$ |
|
||||
| 2014 Notes, maturing 2025, fixed interest rate |
|
|
||||||
| 2020 Notes, maturing 2028, fixed interest rate |
|
|
||||||
| $ | 588.6 | $ | 653.3 | |||||
| March 31, 2022 | December 31, 2021 | |||||||
| Trade accounts receivable | $ |
|
$ |
|
||||
| Allowance for current expected credit losses |
(
|
(
|
||||||
| Unbilled receivables |
|
|
||||||
| Taxes receivable |
|
|
||||||
| Other |
|
|
||||||
| $ |
|
$ |
|
|||||
| March 31, 2022 | December 31, 2021 | |||||||
| Logs, chips and sawdust | $ |
|
$ |
|
||||
| Pulp |
|
|
||||||
| Paperboard and tissue products |
|
|
||||||
| Materials and supplies |
|
|
||||||
| $ |
|
$ |
|
|||||
| March 31, 2022 | December 31, 2021 | |||||||
| Trade payables | $ |
|
$ |
|
||||
| Accrued compensation |
|
|
||||||
| Operating lease liabilities |
|
|
||||||
| Accrued interest |
|
|
||||||
| Accrued taxes other than income |
|
|
||||||
| Other accrued liabilities |
|
|
||||||
| $ |
|
$ |
|
|||||
| Quarter Ended March 31, | ||||||||
| 2022 | 2021 | |||||||
| Reorganization and other expenses | $ |
|
$ |
|
||||
| Mill closure costs |
|
|
||||||
| Directors' equity-based compensation expense |
(
|
|
||||||
| $ |
|
$ |
|
|||||
| Quarter Ended March 31, | ||||||||
| 2022 | 2021 | |||||||
| Interest expense | $ |
(
|
$ |
(
|
||||
| Amortization of debt issuance costs |
(
|
(
|
||||||
| Interest income |
|
|
||||||
| Interest expense, net |
(
|
(
|
||||||
| Debt retirement costs |
(
|
|
||||||
| Non-operating pension and other postretirement employee benefits expense |
(
|
(
|
||||||
| Total non-operating expense | $ |
(
|
$ |
(
|
||||
| Quarter Ended March 31, | ||||||||
| Pension Benefit Plans | 2022 | 2021 | ||||||
| Service cost | $ |
|
$ |
|
||||
| Interest cost |
|
|
||||||
| Expected return on plan assets |
(
|
(
|
||||||
| Amortization of actuarial loss |
|
|
||||||
| Net periodic cost | $ |
|
$ |
|
||||
| Quarter Ended March 31, | ||||||||||||||||||||
| Other Postretirement Employee Benefit Plans | 2022 | 2021 | ||||||||||||||||||
| Service cost | $ |
|
$ |
|
||||||||||||||||
| Interest cost |
|
|
||||||||||||||||||
| Net periodic cost | $ |
|
$ |
|
||||||||||||||||
| Pension Plan Adjustments | Other Post Retirement Employee Benefit Plan Adjustments | Total | |||||||||
| Balance at December 31, 2020 | $ |
(
|
$ |
|
$ |
(
|
|||||
| Amounts reclassified from accumulated other comprehensive loss |
|
|
|
||||||||
| Balance at March 31, 2021 | $ |
(
|
$ |
|
$ |
(
|
|||||
| Balance at December 31, 2021 | $ |
(
|
$ |
|
$ |
(
|
|||||
| Amounts reclassified from accumulated other comprehensive loss |
|
|
|
||||||||
| Balance at March 31, 2022 | $ |
(
|
$ |
|
$ |
(
|
|||||
| Quarter Ended March 31, | ||||||||
| 2022 | 2021 | |||||||
|
Total stock-based compensation expense
(selling, general and administrative and other operating charges, net)
|
$ |
|
$ |
|
||||
| Income tax benefit related to stock-based compensation | $ |
|
$ |
|
||||
| Impact on cash flow due to taxes paid related to net share settlement of equity awards | $ |
|
$ |
|
||||
| Quarter Ended March 31, | ||||||||
| (In thousands) | 2022 | 2021 | ||||||
| Basic weighted-average common shares outstanding |
|
|
||||||
| Incremental shares due to: | ||||||||
| Stock-based awards |
|
|
||||||
| Performance shares |
|
|
||||||
| Diluted weighted-average common shares outstanding |
|
|
||||||
| Quarter Ended March 31, | ||||||||
| 2022 | 2021 | |||||||
| Segment net sales: | ||||||||
| Pulp and Paperboard | $ |
|
$ |
|
||||
| Consumer Products |
|
|
||||||
| Eliminations |
(
|
(
|
||||||
| Net sales | $ |
|
$ |
|
||||
| Operating income (loss): | ||||||||
| Pulp and Paperboard | $ |
|
$ |
|
||||
| Consumer Products |
|
|
||||||
| Corporate and eliminations |
(
|
(
|
||||||
| Other operating charges, net |
(
|
(
|
||||||
| Income from operations | $ |
|
$ |
|
||||
| Quarter Ended March 31, | ||||||||
| 2022 | 2021 | |||||||
| Major products: | ||||||||
| Paperboard | $ |
|
$ |
|
||||
| Retail tissue |
|
|
||||||
|
Away-from-home tissue
1
|
|
|
||||||
| Pulp |
|
|
||||||
| Other |
|
|
||||||
| Eliminations |
(
|
(
|
||||||
| Total net sales | $ |
|
$ |
|
||||
| ITEM 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | ||||
| Quarter Ended March 31, | ||||||||
| (In millions) | 2022 | 2021 | ||||||
| Net income | $ | 16.6 | $ | 12.1 | ||||
| Income tax provision | 6.0 | 3.2 | ||||||
| Interest expense, net | 8.6 | 9.3 | ||||||
| Depreciation and amortization | 25.4 | 26.8 | ||||||
| Other operating charges, net | 0.5 | 0.4 | ||||||
| Debt retirement costs | 0.2 | — | ||||||
| Other non-operating expense | 1.4 | 2.5 | ||||||
| Adjusted EBITDA | $ | 58.9 | $ | 54.3 | ||||
| Pulp and Paperboard segment income | $ | 50.3 | $ | 25.0 | ||||
| Depreciation and amortization | 9.3 | 9.0 | ||||||
| Adjusted EBITDA Pulp and Paperboard segment | $ | 59.5 | $ | 34.0 | ||||
| Consumer Products segment income | $ | 0.9 | $ | 17.9 | ||||
| Depreciation and amortization | 15.3 | 16.8 | ||||||
| Adjusted EBITDA Consumer Products segment | $ | 16.2 | $ | 34.7 | ||||
| Corporate and other expense | $ | (17.8) | $ | (15.5) | ||||
| Depreciation and amortization | 0.9 | 1.1 | ||||||
| Adjusted EBITDA Corporate and other | $ | (16.9) | $ | (14.4) | ||||
| Pulp and Paperboard segment | $ | 59.5 | $ | 34.0 | ||||
| Consumer Products segment | 16.2 | 34.7 | ||||||
| Corporate and other | (16.9) | (14.4) | ||||||
| Adjusted EBITDA | $ | 58.9 | $ | 54.3 | ||||
| Quarter Ended March 31, | ||||||||||||||
| (Dollars in millions, except per ton amounts) | 2022 | 2021 | Increase (decrease) | |||||||||||
| Sales: | ||||||||||||||
| Paperboard | $ | 254.3 | $ | 212.4 | 19.7 | % | ||||||||
| Pulp | 8.3 | 3.5 | 140.1 | % | ||||||||||
| Other | 3.6 | 3.9 | (6.2) | % | ||||||||||
| $ | 266.2 | $ | 219.7 | 21.2 | % | |||||||||
| Operating income | $ | 50.3 | $ | 25.0 | 100.8 | % | ||||||||
| Operating margin | 18.9 | % | 11.4 | % | ||||||||||
| Adjusted EBITDA | $ | 59.5 | $ | 34.0 | 75.0 | % | ||||||||
| Adjusted EBITDA margin | 22.4 | % | 15.5 | % | ||||||||||
| Paperboard shipments (short tons) | 201,356 | 206,712 | (2.6) | % | ||||||||||
| Paperboard sales price (per short ton) | $ | 1,263 | $ | 1,028 | 22.9 | % | ||||||||
| Quarter Ended March 31, | ||||||||||||||
| (Dollars in millions, except per unit) | 2022 | 2021 | Increase (decrease) | |||||||||||
| Sales: | ||||||||||||||
| Retail tissue | $ | 216.6 | $ | 195.1 | 11.0 | % | ||||||||
|
Away-from-home
1
|
— | 6.5 | (100.0) | % | ||||||||||
| Other | 6.4 | 6.7 | (4.0) | % | ||||||||||
| $ | 223.0 | $ | 208.4 | 7.0 | % | |||||||||
| Operating income | $ | 0.9 | $ | 17.9 | (94.8) | % | ||||||||
| Operating margin | 0.4 | % | 8.6 | % | ||||||||||
| Adjusted EBITDA | $ | 16.2 | $ | 34.7 | (53.2) | % | ||||||||
| Adjusted EBITDA margin | 7.3 | % | 16.6 | % | ||||||||||
| Shipments (short tons) | ||||||||||||||
| Retail | 75,426 | 70,762 | 6.6 | % | ||||||||||
|
Away-from-home
1
|
— | 3,454 | (100.0) | % | ||||||||||
| Other | 5,073 | 5,969 | (15.0) | % | ||||||||||
| 80,499 | 80,185 | 0.4 | % | |||||||||||
| Sales price (per short ton) | ||||||||||||||
| Retail | $ | 2,872 | $ | 2,758 | 4.1 | % | ||||||||
| ITEM 3. | Quantitative and Qualitative Disclosures About Market Risk | ||||
| ITEM 4. | Controls and Procedures | ||||
| ITEM 1. | Legal Proceedings | ||||
| ITEM 1A. | Risk Factors | ||||
|
EXHIBIT
NUMBER |
DESCRIPTION | |||||||
| 31** | ||||||||
| 32** | ||||||||
| 101.INS | XBRL Instance Document | |||||||
| 101.SCH | XBRL Taxonomy Extension Schema. | |||||||
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase. | |||||||
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase. | |||||||
| 101.LAB | XBRL Taxonomy Extension Label Linkbase. | |||||||
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase. | |||||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). | |||||||
|
**
|
In accordance with Item 601(b)(32)(ii) of Regulation S-K and SEC Release No. 34-47986, the certifications furnished in Exhibit 32 hereto are deemed to accompany this Form 10-Q and will not be deemed “filed” for purposes of Section 18 of the Exchange Act. Such certifications will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act. | ||||
| CLEARWATER PAPER CORPORATION | ||||||||||||||
| (Registrant) | ||||||||||||||
| April 28, 2022 | By: | /s/ ARSEN S. KITCH | ||||||||||||
| Arsen S. Kitch | ||||||||||||||
| President, Chief Executive Officer and Director (Principal Executive Officer) | ||||||||||||||
| April 28, 2022 | By: | /s/ MICHAEL J. MURPHY | ||||||||||||
| Michael J. Murphy | ||||||||||||||
| Senior Vice President, Finance and Chief Financial Officer (Principal Financial Officer) | ||||||||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|